| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| KLM Kevin L. Mccreless CONCOURSE FINANCIAL GROUP SECURITIES Inc. | 2,109 | $56,415.75 | $83,853.84 | $27,438.09 | 48.64% |
| BATS Exchange | US Country |
The fund described aims to fulfill its investment objective by allocating at least 80% of its net assets, alongside any borrowings intended for investment purposes, into the component securities that make up its index. This index has been specifically crafted to monitor the performance of a strategy focused on investing in U.S. publicly traded companies. A distinctive feature of these targeted companies is their robust free cash flow alongside significant investments in research and development (R&D), signaling a commitment to innovation and growth. By following this approach, the fund seeks to offer investors equity exposure to firms that are not only financially healthy but are also at the forefront of technological and industrial advancements, potentially paving the way for sustained profitability and market leadership.
The core product of the fund involves the investment in component securities of the targeted index. This index is meticulously constructed to include U.S. publicly traded companies distinguished by their strong free cash flow and aggressive R&D investments. This investment strategy is designed to optimize equity exposure to high-performing companies, thereby offering the potential for robust returns to investors.
By focusing on companies with strong free cash flow and significant R&D expenditure, the fund aims to provide investors with exposure to firms that are not only financially solid but are also leaders in innovation. This dual focus ensures that investors benefit from both the protective measures of financial health and the growth potential offered by cutting-edge research and development efforts.